Results 221 to 230 of about 115,427 (296)

Impact of a robotic-assisted transperineal biopsy platform on pathologic upgrading and downgrading at prostatectomy. [PDF]

World J Urol
Alargkof V, Walter M, Engesser C, Nueesch L, Breit HC, Winkel DJ, Seifert HH, Vlajnic T, Wetterauer C, Trotsenko P.   +9 more
europepmc   +1 more source

Single+1 Port Robotic Splenectomy Using the da Vinci SP System—Experience of a Single Centre

The International Journal of Medical Robotics and Computer Assisted Surgery, Volume 22, Issue 2, April 2026.
ABSTRACT Background Laparoscopic splenectomy is the standard procedure for benign splenic disease but remains challenging in splenomegaly or complex hilar anatomy. The da Vinci SP system offers enhanced dexterity and visualisation via a single port. Methods We retrospectively reviewed six female patients who underwent single+1 port robotic splenectomy ...
Yeongsoo Jo, Seog Ki Min
wiley   +1 more source

Corrigendum: Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer

Frontiers in Oncology
Won Sik Ham, Jee Soo Park, Won Sik Jang, Jongchan Kim, Jongchan Kim   +4 more
doaj   +1 more source

Two faces of malignancy in one prostate: A rare coexistence of adenocarcinoma and leiomyosarcoma. [PDF]

Urol Case Rep
Tran TT, Nguyen KK, Thai NT, Tran GH, Luong KA.   +4 more
europepmc   +1 more source

Post‐Therapeutic Dosimetry of Metastatic Castration‐Resistant Prostate Cancer With 177Lu‐PSMA: Experiences From Two University‐Based Hospitals in Thailand

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 199-206, April 2026.
ABSTRACT Objective 177Lu‐PSMA radioligand therapy (RLT) is increasingly used to treat metastatic castration‐resistant prostate cancer (mCRPC). Posttreatment dosimetry is essential for assessing normal organ absorbed doses. Therefore, this study aims to evaluate normal organs dosimetry in mCRPC patients undergoing 177Lu‐PSMA‐RLT from two university ...
Onnicha Pattanawong, Putthiporn Charoenphun, Wichana Chamroonrat, Thonnapong Thongpraparn, Nucharee Poon‐iad, Benjapa Khiewvan, Krisanat Chuamsaamarkkee   +6 more
wiley   +1 more source

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population‐based study

BJU International, Volume 137, Issue 4, Page 629-638, April 2026.
Objective To estimate risk of prostate‐specific antigen (PSA) relapse after radical radiotherapy (RT) for prostate cancer (PCa), and risk of PCa death after relapse according to Gleason score and time to relapse. Patients and Methods Men in the National Prostate Cancer Register of Sweden who underwent primary radical RT in 2007–2024 were followed until
Paolo Zaurito, Hans Garmo, Rolf Gedeborg, Mats Alhberg, Stefan Carlsson, Camilla Thellenberg, David Robinson, Pär Stattin, Marcus Westerberg   +8 more
wiley   +1 more source

LUMBER: A feasible MRI-based 3D printed mould platform for ex vivo sampling of prostate cancer. [PDF]

BJUI Compass
Du C, Rac G, Lanzotti N, Ellis J, Chen V, Picken MM, Barkan GA, Woods M, Gorbonos A, Quek M, Shea SM, Gupta GN.   +11 more
europepmc   +1 more source

Diagnostic accuracy and outcomes of lymph node staging in intermediate‐risk prostate cancer

BJU International, Volume 137, Issue 4, Page 667-676, April 2026.
Objective To evaluate the diagnostic performance of different staging modalities and oncological outcomes in patients with intermediate‐risk (IR) prostate cancer (PCa) undergoing radical prostatectomy (RP) with pelvic lymph node dissection (PLND).
Christopher Kniep, Tobias Maurer, Ben Frederik Hartwieg, Philipp Mandel, Mike Wenzel, Fabian Falkenbach, Kristian Krpina, Lars Budäus, Alexander Haese, Georg Salomon, Thomas Steuber, Markus Graefen, Derya Tilki, Felix Preisser   +13 more
wiley   +1 more source

Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer

BJU International, Volume 137, Issue 4, Page 716-727, April 2026.
Objective To prospectively evaluate functional patient‐reported outcomes (PROs) in patients with low‐risk prostate cancer (PCa) managed with active surveillance (AS), nerve‐sparing radical prostatectomy (NS‐RP), non‐NS‐RP, or radiotherapy (RT). Patients and Methods This multicentre prospective cohort study used data from the Prostate Cancer Outcomes ...
Mulham Al‐Nader, Claudia Kesch, Osama Mahmoud, Boris A. Hadaschik, Jan Fichtner, Guenther Carl, Günter Feick, Martin Burchardt, Volker Zimmermanns, Lukas Prause, Bülent Polat, Andreas Blana, Marcus Horstmann, Matthias Saar, Petra Miglierini, Kinan Almansur, Lukas Hefermehl, Daniel Porres, Inga Peters, Kristina Wiens, Rein Jüri Palisaar, Alexander Winter, Andreas Neisius, Eva‐Maria Kunzmann, Nina Natascha Harke, Christian Bolenz, Mohamad Hatem Albarghouth, Lukas Manka, Mario Kramer, Ferdinand Luger, Thomas Knoll, Jesco Pfitzenmaier, Marko Brock, Julia Schittko, Jens Peter Sommer, Matthias Reichert, Sebastian Lenart, Philipp Huber, Sameh Hijazi, Anna Calderaro, Thomas Hermanns, Jens Tonhauser, Christoph Kowalski, Nora Tabea Sibert   +43 more
wiley   +1 more source